This training on FDA compliance will provide the attendees with an understanding of FDA expectations regarding end-of-phase 2A meeting guidance. Attendees will learn the best practices to comply with the intent of the guidance and to achieve a higher quality outcome from the meeting.
Driving Quality and Compliance in Drug Development Through the FDA End-of-Phase 2A Meeting
23 January 2014, Palo Alto, United States
Introduction
Venue
Online Event
Online Event, 2600 E. Bayshore Road, Palo Alto, 94303, United States
Organised by
ComplianceOnlinr
Contact information
Related events
The 5th International Conference on Emerging Advanced Nanomaterials ICEAN 2024
4 November 2024 08:00 - 8 November 2024 18:00, Newcastle, Australia
Future Labs Live
26 June 2024 08:00 - 27 June 2024 17:00, Basel, Switzerland
6th International Conference on Nanomaterials Science and Mechanical Engineering
9 - 12 July 2024, Aveiro, Portugal
European Glycoscience Community Webinar Series
25 January 2024 15:00 - 19 December 2024 18:00
Search
Advertisement
Spotlight
Explore
